Camlin Fine Sciences Limited has published its postal ballot notice in newspapers and filed regulatory disclosures seeking shareholder approval to increase its authorized share capital, marking a significant corporate development for the specialty chemicals company. The company filed the newspaper publication notice with stock exchanges on April 8, 2026, pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Proposed Capital Structure Changes

The company seeks to increase its authorized share capital through an ordinary resolution that requires member approval via remote e-voting. The proposed changes represent a strategic move to provide greater financial flexibility for future operations.

E-Voting Process and Timeline

The company has established a comprehensive e-voting framework to facilitate shareholder participation in the decision-making process. National Securities Depository Limited (NSDL) will provide the remote e-voting facility for all eligible members.

Members whose names appear on the register of members or list of beneficial owners as on the cut-off date will be eligible to participate in the e-voting process. The postal ballot notice has been sent electronically to members whose email addresses are registered with the company or depositories.

Regulatory Compliance and Publication

The company filed the newspaper publication notice with BSE Limited and National Stock Exchange of India Limited on April 8, 2026. The notice was published in Financial Express (English) and Loksatta (Marathi) newspapers as required under regulatory provisions. Company Secretary Rahul Sawale signed the regulatory filing confirming compliance with disclosure requirements.

Scrutinizer Appointment and Governance

The Board of Directors has appointed JHR & Associates, Practicing Company Secretary, as the scrutinizer for conducting the postal ballot process. The appointment includes multiple partners to ensure continuity and proper oversight of the voting process.

Strategic Rationale and Future Plans

According to the explanatory statement, the proposed increase in authorized share capital aims to facilitate future fund-raising activities through various modes. The company has outlined several potential avenues for capital mobilization that the enhanced structure would support.

The increased authorized capital would enable the company to pursue:

• Rights issues to existing shareholders
• Qualified Institutional Placements (QIP)
• Preferential allotments
• Private placements
• Public issues of equity shares

The resolution also necessitates a consequential amendment to Clause V of the company's Memorandum of Association to reflect the new capital structure. The proposed amendment will provide the company with enhanced flexibility to meet its strategic objectives and capitalize on growth opportunities.

Documentation and Access

The postal ballot process complies with Section 110 of the Companies Act, 2013, and Rule 20 and Rule 22 of the Companies (Management and Administration) Rules, 2014. The company has also ensured adherence to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable regulatory frameworks.

Shareholders can access the complete postal ballot notice on the company's website at www.camlins.com , as well as on the websites of BSE Limited and National Stock Exchange of India Limited. The notice includes comprehensive instructions for the e-voting process and guidelines for shareholders holding securities in both demat and physical modes.

Camlin Fine Sciences Limited has received a significant tax demand order from GST authorities, requiring the company to pay ₹96,65,820 for alleged tax violations related to foreign currency transactions. The order was issued by the Office of the Assistant/Deputy Commissioner of CGST & Central Excise, Division-IV, Palghar Commissionerate and received by the company on March 30, 2026.

Tax Demand Details

The comprehensive order encompasses multiple financial obligations for the company:

The total financial exposure could potentially exceed ₹1.93 crore excluding the interest component, which will be calculated as per applicable provisions.

Nature of Alleged Violations

The tax demand stems from alleged non-compliance with Reverse Charge Mechanism (RCM) provisions during a four-year period. The order specifically addresses:

• Tax liability on expenses incurred in foreign currency
• Reimbursements made to foreign subsidiaries
• Non-payment of tax under RCM for financial years 2019-20 to 2022-23
• Violations under CGST Act, 2017 along with corresponding MGST Act, 2017 and IGST Act, 2017

The authorities have invoked Section 74(9) of the CGST Act, 2017, which deals with determination of tax not paid or short paid or erroneously refunded or input tax credit wrongly availed.

Company's Response and Impact Assessment

Camlin Fine Sciences has provided a measured response to the tax order, emphasizing minimal operational disruption:

The company has stated that it has examined the order and is in the process of filing an appeal against the demand. This indicates the company disputes the allegations and believes it has grounds to challenge the order before appellate authorities.

Regulatory Compliance

The disclosure has been made in compliance with Regulation 30 read with sub-para 20 of Para A of Part A of Schedule III of the SEBI Listing Regulations, 2015. This regulation mandates listed companies to inform stock exchanges about orders passed by regulatory authorities that may have material impact on the company's operations or finances.

The company has simultaneously informed both BSE Limited and National Stock Exchange of India about this development, ensuring full transparency with market participants and regulatory bodies.